View in EDS HTML Full Text PDF Full Text

Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring.

Saved in:
Bibliographic Details
Title: Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring.
Authors: Omran MM; Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, 11796, Egypt. Mervat.omran@nci.cu.edu.eg., Ibrahim AB; Department of Pharmacology, Faculty of Medicine, Zawia University, Zawia, Libya., Abdelfattah R; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Shouman SA; Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, 11796, Egypt., Hamza MS; Clinical Pharmacy Practice Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo, Egypt.
Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Jul; Vol. 80 (7), pp. 1061-1068. Date of Electronic Publication: 2024 Mar 27.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38536418
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Omran+MM%22">Omran MM</searchLink>; Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, 11796, Egypt. Mervat.omran@nci.cu.edu.eg.<br /><searchLink fieldCode="AU" term="%22Ibrahim+AB%22">Ibrahim AB</searchLink>; Department of Pharmacology, Faculty of Medicine, Zawia University, Zawia, Libya.<br /><searchLink fieldCode="AU" term="%22Abdelfattah+R%22">Abdelfattah R</searchLink>; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.<br /><searchLink fieldCode="AU" term="%22Shouman+SA%22">Shouman SA</searchLink>; Pharmacology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, 11796, Egypt.<br /><searchLink fieldCode="AU" term="%22Hamza+MS%22">Hamza MS</searchLink>; Clinical Pharmacy Practice Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo, Egypt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%221256165%22">European journal of clinical pharmacology</searchLink> [Eur J Clin Pharmacol] 2024 Jul; Vol. 80 (7), pp. 1061-1068. <i>Date of Electronic Publication: </i>2024 Mar 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>1256165 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200316970%22">00316970 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38536418
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00228-024-03675-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1061
    Titles:
      – TitleFull: Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Omran MM
      – PersonEntity:
          Name:
            NameFull: Ibrahim AB
      – PersonEntity:
          Name:
            NameFull: Abdelfattah R
      – PersonEntity:
          Name:
            NameFull: Shouman SA
      – PersonEntity:
          Name:
            NameFull: Hamza MS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1432-1041
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: European journal of clinical pharmacology
              Type: main
ResultId 1